-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q3 2025.
- Taysha Gene Therapies, Inc. Depreciation for the quarter ending September 30, 2025 was $200K, a 33.3% decline year-over-year.
- Taysha Gene Therapies, Inc. Depreciation for the twelve months ending September 30, 2025 was $1.1M, a 12.8% decline year-over-year.
- Taysha Gene Therapies, Inc. annual Depreciation for 2024 was $1.25M, a 9.19% decline from 2023.
- Taysha Gene Therapies, Inc. annual Depreciation for 2023 was $1.37M, a 17% increase from 2022.
- Taysha Gene Therapies, Inc. annual Depreciation for 2022 was $1.17M, a 138% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)